Compared with CCR5– T cells, CCR5+ T cells have been shown to have a greater ability to migrate to tumor sites [45,46] CCR5+CD4+ T cells are necessary for the adaptive immune response in tumors. This evidence concerns the gene CD4 and neoplasm.